Table 4.
Youden Indices of biomarker sets for the diagnosis of OA.
| Model | Threshold based on optimal Youden’s index in training dataset | Sensitivity in testing dataset using training dataset threshold [95% CIs] |
Specificity in testing dataset using training dataset threshold [95% CIs] |
|---|---|---|---|
| BMI | 0.82 | 0.52 (0.46,0.59) | 0.60 (0.54,0.66) |
| BMI, age, sex | 0.85 | 0.42 (0.36,0.49) | 0.82 (0.77,0.87) |
| ACTG | 0.8 | 0.71 (0.66,0.77) | 0.62 (0.56,0.68) |
| ACTG + BMI | 0.73 | 0.71 (0.65,0.77) | 0.67 (0.61,0.73) |
| 23 RF peptides | 0.86 | 0.81 (0.75,0.86) | 0.82 (0.77,0.87) |
| 23 RF peptides + BMI | 0.81 | 0.86 (0.81,0.9) | 0.76 (0.7,0.81) |
| 17 uncorrelated peptides | 0.83 | 0.77 (0.72,0.83) | 0.84 (0.8,0.89) |
| 17 uncorrelated peptides + BMI | 0.79 | 0.88 (0.83,0.92) | 0.73 (0.68,0.79) |
| 8 significant peptides | 0.81 | 0.78 (0.73,0.84) | 0.78 (0.72,0.83) |
| 8 significant peptides + BMI | 0.9 | 0.94 (0.91,0.97) | 0.69 (0.63,0.75) |